SPECIAL NOTICE
B -- Post-Market Bioequivalence (BE) Studies
- Notice Date
- 11/21/2025 10:56:21 AM
- Notice Type
- Special Notice
- NAICS
- 541715
— Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Contracting Office
- FDA OFFICE OF ACQ GRANT SVCS Beltsville MD 20705 USA
- ZIP Code
- 20705
- Response Due
- 11/21/2025 11:20:00 AM
- Archive Date
- 11/21/2025
- Point of Contact
- Telisha Wilson, Phone: 2404027572
- E-Mail Address
-
telisha.wilson@fda.hhs.gov
(telisha.wilson@fda.hhs.gov)
- Small Business Set-Aside
- NONE No Set aside used
- Description
- This notication serves as a cancellation of a requirement in name FDAFO121683-Post-Market Bioequivalence (BE) Studies
- Web Link
-
SAM.gov Permalink
(https://sam.gov/workspace/contract/opp/1303d7fd61d7428e8949ce0ba34b8f5b/view)
- Record
- SN07648901-F 20251123/251121230035 (samdaily.us)
- Source
-
SAM.gov Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's SAM Daily Index Page |